Avantor® Announces Filing of Registration Statement for Initial Public Offering

Radnor, Pa, February 8,2019 – Avantor, Inc., a leading global provider of mission critical products and services to customersin the Biopharma, Healthcare, Education & Government, and Advanced Technologies & Applied Materials industries, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to the proposed initial public offering (“IPO”) and listing of Avantor’s common stock.

A registration statement relating to the proposed IPO has been filed with the SEC but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction.

Download press release PDF

Avantor® is a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries. The company operates in more than 30 countries and delivers an extensive portfolio of products and services. As our channel brand, VWR offers an integrated, seamless purchasing experience that is optimized for the way our customers do business. We set science in motion to create a better world. For information visit, www.avantorsciences.com and find us on Linkedin, Twitter and Facebook.